MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Out-licensing

Reliable, Reproducible Induction of Fibroblasts for Bioengineered Fibrous Tissue

Columbia Technology Ventures
Name of the primary inventor: Jeremy Mao. Invention: Method of inducing fibroblast differentiation from human mesenchymal stem cells (adult stem cells) Unmet Need: Currently, there exists no reliable and convenient way to differentiate stem cells or...

Full description

Name of the primary inventor: Jeremy Mao. Invention: Method of inducing fibroblast differentiation from human mesenchymal stem cells (adult stem cells) Unmet Need: Currently, there exists no reliable and convenient way to differentiate stem cells or progenitor cells into fibroblasts. Advances: Reliable, reproducible method Chemical rather than mechanical induction Higher yield of available cells Applications: Fibroblasts maintain the structural integrity of connective tissues by continuously secreting precursors of the extracellular matrix that synthesize collagen, fibronectin and other important extracellular matrix molecules. Thus, fibroblasts are an essential component of engineered fibrous tissue grafts that may be used to repair tendons, ligaments, cranial sutures, fascia, periosteum, interstitial fibrous tissues, and other connective tissues. Market Size: May be integrated with other bioengineering approaches requiring such cells for seeding on scaffolds or other biomaterials. References: Lee CH et al. Conf Proc IEEE Eng Med Biol Soc. 2006; 1:775-8.

Patent information

Pat. Title: Differentiation of progenitor cells into fibroblasts Differentiation of Progenitor Cells Into Fibroblasts

Publication #: WO 2008/024447

App. #: 60/823,250 PCT/US07/18670

Type of business relationship sought

Licensing or sponsored research support

Licensing contact

Donna K. See
Technology Licensing

Contact directly

Company details

Columbia Technology Ventures

Columbia Technology Ventures manages Columbia University’s intellectual property portfolio and serves as the University’s gateway for companies seeking novel technology solutions.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us